mupirocin and Abscess

mupirocin has been researched along with Abscess* in 7 studies

Reviews

1 review(s) available for mupirocin and Abscess

ArticleYear
Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
    Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:9

    Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Communicable Diseases, Emerging; Female; Foot Diseases; Fusidic Acid; Humans; Insect Bites and Stings; Male; Middle Aged; Mupirocin; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus lugdunensis; Wound Infection

2015

Other Studies

6 other study(ies) available for mupirocin and Abscess

ArticleYear
Genomic Basis of Occurrence of Cryptic Resistance among Oxacillin- and Cefoxitin-Susceptible
    Microbiology spectrum, 2022, 06-29, Volume: 10, Issue:3

    The oxacillin- and cefoxitin-susceptible

    Topics: Abscess; Anti-Bacterial Agents; Bacterial Proteins; Cefoxitin; Female; Genomics; Humans; Lactation; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Oxacillin; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus

2022
Decolonization of children after incision and drainage for MRSA abscess: a retrospective cohort study.
    Clinical pediatrics, 2015, Volume: 54, Issue:5

    Whether decolonization following incision and drainage (I&D) for methicillin-resistant Staphylococcus aureus (MRSA) abscess decreases repeat I&D and MRSA-positive cultures in children is unknown.. Referral to the Pediatric Infectious Disease Service (PIDS) for decolonization was determined for eligible children (2003-2010), with outcomes studied over 12 months.. We identified 653 children; 54 had been seen by PIDS. In the PIDS group, no patients (0/54, 0%) had a repeat I&D. In the no PIDS group 36/599 (6%) had a repeat I&D, P = .06. Logistic regression modeling for repeat I&D showed no significant effect, odds ratio = 0.29; 95% confidence interval = 0.04-2.15; P = .23. In the PIDS group, 3 patients (3/54, 5.6%) had a repeat MRSA-positive culture. In the no PIDS group, 58/599 (9.7%) had a positive repeat culture, P = .46. Logistic regression modeling for positive culture showed no significant effect (odds ratio = 0.55; 95% confidence interval = 0.17-1.81; P = .32).. We detected no statistically significant association between decolonization and repeat I&D or MRSA-positive culture.

    Topics: Abscess; Administration, Intranasal; Anti-Bacterial Agents; Baths; Child; Child, Preschool; Cohort Studies; Disinfectants; Drainage; Female; Humans; Longitudinal Studies; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Risk Factors; Sodium Hypochlorite; Staphylococcal Infections; Treatment Outcome

2015
[Bacterial lip abscess in an immunocompetent patient].
    Dermatology online journal, 2013, Apr-15, Volume: 19, Issue:4

    Lip abscesses are a potentially serious condition rarely reported in the medical literature. This disease requires prompt diagnosis and treatment with hospitalization, intravenous antibiotics, and urgent surgical drainage. Clinical knowledge of this condition is essential to guide the differential diagnosis and correctly adapt the etiological treatment. The presence of necrotic and cavitated lesions requires ruling out immunosupression or methicillin-resistant agent. We report a necrotic and cavitated bacterial lip abscess caused by methicillin-sensitive Staphylococcus aureus in an immunocompetent male.

    Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cheilitis; Cloxacillin; Combined Modality Therapy; Drainage; Humans; Immunocompetence; Male; Mupirocin; Staphylococcal Skin Infections; Staphylococcus aureus

2013
Community-acquired methicillin-resistant staphylococcus aureus skin infection.
    Journal of pediatric and adolescent gynecology, 2011, Volume: 24, Issue:4

    Topics: Abscess; Adolescent; Anti-Bacterial Agents; Combined Modality Therapy; Community-Acquired Infections; Doxycycline; Drainage; Drug Therapy, Combination; Female; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Staphylococcal Skin Infections

2011
Stamping out Staphylococcus.
    Clinical immunology (Orlando, Fla.), 2004, Volume: 113, Issue:1

    Topics: Abscess; Administration, Intranasal; Adult; Anti-Bacterial Agents; Down Syndrome; Humans; Male; Methicillin Resistance; Mupirocin; Staphylococcal Skin Infections; Staphylococcus aureus

2004
Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.
    Journal of medicinal chemistry, 2002, May-09, Volume: 45, Issue:10

    Potent nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase have been derived from a file compound high throughput screening hit. Optimized compounds show excellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics. Compound 11 demonstrated in vivo efficacy in an S. aureus rat abscess infection model.

    Topics: Abscess; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Enzyme Inhibitors; Methionine-tRNA Ligase; Quinolones; Rats; Rats, Sprague-Dawley; Staphylococcus; Staphylococcus aureus; Structure-Activity Relationship

2002